Clinical and genetic characterization of intellectual disability
This study examines the etiological factors and comorbidities in a large cohort of Finnish patients with intellectual disability. Genetic causes—including chromosomal abnormalities and pathogenic gene variants—were more frequently identified in individuals with moderate to profound intellectual disability.
Aarni Venetvaara +14 more
wiley +1 more source
Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus. [PDF]
Qiao Y +10 more
europepmc +1 more source
The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia [PDF]
Alexandros Rammos +4 more
openalex +1 more source
Abstract Introduction Type 2 diabetes is a complex condition with a multifactorial pathogenesis. The pathogenesis is considered to be polygenic due to complex interactions between genetic/epigenetic and environmental factors. The aim of this study is to determine the genetic, environmental and lifestyle factors associated with the development of type 2
Sunny Chinenye +18 more
wiley +1 more source
Associations Between Polygenic Risk Score for Blood Pressure and Risk of Hypertension in Northeast Asian Individuals. [PDF]
Kim NY, Park J, Nam K, Lee S, Lee H.
europepmc +1 more source
The relationship between polygenic risk scores and cognition in Schizophrenia
Walters J.T.R. +50 more
openalex +1 more source
Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes
ABSTRACT Aims Type 2 diabetes mellitus (T2DM) has been inversely associated with prostate cancer (PrCa) risk. However, it remains unclear whether a polygenic risk score (PRS) for PrCa can effectively stratify risk among men with T2DM. The primary objective of this study was to assess whether a PrCa PRS predicts PrCa risk independently of T2DM status ...
Guk Jin Lee +32 more
wiley +1 more source
Novel polygenic risk score associates with diverticulitis in a multi-institutional, ancestrally diverse cohort. [PDF]
Neylan CJ +12 more
europepmc +1 more source
A Modular Pipeline for the Construction and Validation of Polygenic Risk Scores in Oncology
Eleonora Pascucci +3 more
openalex +1 more source
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley +1 more source

